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Abstract: Periostin (Postn) is a heterofunctional secreted extracellular matrix (ECM) protein comprised of four fasciclin 
domains that promotes cellular adhesion and movement, as well as collagen fibrillogenesis. Postn is expressed in unique 
growth centers during embryonic development where it facilitates epithelial-mesenchymal transition (EMT) of select cell 
populations undergoing reorganization. In the heart, Postn is expressed in the developing valves, cardiac fibroblasts and in 
regions of the outflow track. In the adult, Postn expression is specifically induced in areas of tissue injury or areas with 
ongoing cellular re-organization. In the adult heart Postn is induced in the ventricles following myocardial infarction, 
pressure overload stimulation, or generalized cardiomyopathy. Here we will review the functional consequences associ-
ated with Postn induction in both the developing and adult heart. The majority of data collected to date suggest a common 
function for Postn in both development and disease as a potent inducible regulator of cellular reorganization and extracel-
lular matrix homeostasis, although some alternate and controversial functions have also been ascribed to Postn, the valid-
ity of which will be discussed here. 
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INTRODUCTION 
  In vertebrates four proteins containing fasciclin domains 
have been described, including Postn, Tgfbi (transforming 
growth factor- (TGF)-inducible protein [also called ig-
H3]), Stabilin-1, and Stabilin-2 [1]. Postn is a 90 kDa se-
creted protein that contains 4 repetitive fasciclin domains 
that are similar in sequence to the insect protein fasciclin [2].
 
Developmentally regulated differential splicing results in 
both matrix and membrane-associated (via amphipathic -
helix) and secreted isoforms. Postn is most closely related to 
Tgfbi, which like Postn is expressed in collagen-rich connec-
tive tissues, remodeling centers and valves, and is induced 
by TGF [3,4].  Fasciclin domain-containing proteins were 
first functionally characterized in the insect where fasciclin 
was shown to regulate axon guidance and homophilic cell-
cell adhesion [2]. Whilst Postn and Tgfbi each contain 4 fas-
ciclin-like adhesion domains and a single EMI protein-
protein interaction module [5], only Tgfbi contains an RGD 
collagen-association motif [3, 4]. Most fasciclin domain con-
taining proteins are GPI anchored and contain two or four 
copies of the domain that are thought to mediate cell adhe-
sion through interaction with various integrins. The zebrafish  
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genome also contains zPostn and zTgfbi homologues, and 
both zebrafish and mouse Postn and Tgfbi genes exhibit sig-
nificant homology to Drosophila fasciclin-I [4], suggesting 
that the vertebrate genes are descendants of a common an-
cestral gene. 
  In contrast to the secreted Postn and Tgfbi proteins, the 
high molecular mass Stabilin-1 (Stab-1) and Stabilin-2 
(Stab-2) proteins uniquely contain 7 fasciclin adhesion do-
mains, numerous epidermal growth factor (EGF)-like do-
mains, a link hyaluronan (HA)-binding domain, and a pre-
dicted transmembrane domain (Fig. 1A). While Stab-1 and 
Stab-2 are structurally similar, they appear to have unique 
functions as Stab-1 acts to clear unwanted self-molecules, 
while Stab-2 acts as a scavenger receptor for HA and AGE-
modified proteins [6,7]. Both putative Stab-1 and Stab-2 
receptors are expressed during development and within en-
dothelial tissues and alternatively activated macrophages in 
the adult spleen, liver, lymph nodes and placenta. All four 
mammalian fasciclin domain-containing genes are expressed 
in the adult heart, whilst only Postn, Tgfbi and Stab-1 are 
present in the in utero developing heart (Fig. 1B-D) [4]. 
Even though several independent but complimentary Postn 
mice knockout studies have begun to shed light upon the 
requirement and possible function of Postn within the car-
diovascular system, the roles of Tgfbi, Stab-1 and Stab-2 
during cardiovascular development and heart homeostasis 
are presently unknown.  
  As a secreted ECM protein that associates with areas of 
fibrosis, Postn can directly interact with other ECM proteins 
such as fibronectin, tenascin-C, collagen I, collagen V, and  
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heparin [8-10].  Postn can serve as a ligand for select in-
tegrins, such as v3, v5, and 46, where it can affect the 
ability of cells (fibroblasts or cancer cells) to migrate and/or  
 
undergo a EMT in select tissues during pathological disease 
progression [11,12]. However, it remains unclear whether 
this ligand-receptor association also occurs during normal 
homeostasis. Postn up regulation is also involved in cell sur-
vival and angiogenesis, and has become known as a promis-
ing marker for tumor progression in various types of human 
cancers [13-15].  
Postn EXPRESSION DURING HEART DEVELOP-
MENT 
 Takeshita  et al.  originally cloned mouse Postn, which 
they designated osteoblast-specific factor-2 (OSF-2), as it 
was robustly expressed within the osteoblastic MC3T3-E1 
cells and bone samples [16]. Mouse and human Postn share 
89.2% amino acid identity, suggesting a high degree of func-
tional conservation. Postn shows a dynamic expression pro-
file, both developmentally and in adult tissues that are un-
dergoing remodeling or active stress. Postn is expressed in 
the developing endocardial cushions of the heart and the 
mature valves, the periosteum and periodontal ligament, in-
jured vessels, tumors and metastatic cancer cells, and in cells 
undergoing EMT [11, 17-19]. With respect to cell type of 
expression,  Postn appears to be expressed exclusively in 
endocardial cushion and fibroblast lineages, or in cells that 
adopt fibroblast-like characteristics following an injury event 
[8, 11, 20-23]. In addition to fibroblasts, Postn is expressed 
in other structures within the developing heart that may or 
may not be fibroblast in origin such as the valvular attach-
ment apparatus, chordae tendineae and epicardial/pericardial 
structures, but is absent from the cardiomyocyte lineage it-
self [4, 10, 16, 17, 20, 21].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Schematic representation of genes for Postn, Tgfbi, Stab-1 and Stab-2 (A) Fasciclin (Fasc) domains, the EMI domain, the EGF-like 
domains (shown as narrow rectangles) and the hyaluronan-binding link domain (shown as circles) are all indicated. The figure is a composite 
of data obtained using CDART at the NCBI site (http://www.ncbi.nlm.nih.gov/Structure/lexington/lexington.cgi) and PROSITE Database of 
protein domains, families and functional sites (http://ca.expasy.org/prosite). (B-D) Analysis of select fasciclin family members in E10.5 
mammalian embryonic hearts. (B) Postn, (C) Stab-1 and (D) Tgfbi mRNA expression analysis via radioactive in situ hybridization (silver 
grains indicate expression). Both Postn and Tgfbi are co-expressed in embryonic outflow tract (arrows), cardiac fibroblasts and the pericar-
dium. However, Postn outflow tract expression is confined to the endocardial cushions, whilst Tgfbi is expressed in both outflow tract, endo-
cardial cushions and adjacent myocardial cuff. Additionally, only Postn is robustly expressed in atrio-ventricular cushions (indicated by *). 
In contrast, the transmembrane Stab-1 gene is expressed in adjacent endothelial lineages (C) Stab-2 expression is not shown as it is confined 
to embryonic liver and is absent from the embryonic heart.
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DEVELOPMENTAL DEFECTS ASSOCIATED WITH 
Postn DELETION IN MICE 
  To investigate the potential developmental functions of 
Postn, a gene deletion strategy was undertaken in mice in 
which the first exon was replaced with a lacZ reporter gene 
[24] or exons 4 through
 10 encoding three of the 4 fasciclin 
domains were deleted by insertion of a neomycin cassette 
[21]. Both mutants produced
 null alleles, and will hereafter 
be termed PostnlacZ/lacZ and Postn
-/- mice. Although Postn is 
widely expressed in many developing organ systems, the 
majority of both PostnlacZ/lacZ and Postn
-/- mice survived well 
into adulthood, although they presented with smaller overall 
body weights. Even though ~14% of the PostnlacZ/lacZ nulls 
die before weaning, the surviving PostnlacZ/lacZ mice develop 
an early-onset periodontal ligament (PDL) phenotype, with 
profound ultrastructural and
  histological changes in 
ameloblasts and enamel defects. PostnlacZ/lacZ  mutants up 
regulate collagen III and exhibit a disorganized
 ameloblast 
layer that secretes an
  amorphous hypermineralized matrix. 
Significantly, placing PostnlacZ/lacZ  mice on a soft diet re-
duced growth retardation, improved fertility and alleviated 
mechanical strain on the PDL but not postnatal lethality [24]. 
Subsequent deletion of Postn by another group also revealed 
a similar phenotype of smaller body size, as well as defective 
tooth development [9]. Ensuing analysis indicated 
PostnlacZ/lacZ mice exhibited severe periodontal defects after 
tooth eruption [25]. Interestingly, tooth clipping to remove 
masticatory forces rescued the periodontal defects. Using 
Flexicell culture apparatus to generate mechanical stress, 
Postn expression increased in strained PDL cells. This was 
preceded by a transient increase in Tgf mRNA, and Postn 
elevation was blocked by addition of TGF-neutralizing 
antibodies [25]. Combined, these data suggest that Postn is 
essential for the proper function of the PDL during absor-
bance of strain and maintenance of the integrity in response 
to mechanical stresses.  
CARDIOVASCULAR PHENOTYPE OF MICE LACK-
ING Postn 
  Analysis of the cardiovascular system in Postn
lacZ/lacZ and 
Postn
-/- mice revealed neonatal valvular-dependent lethality 
in a minority of offspring, and latent disease with leaflet ab-
normalities in the viable majority of offspring [20, 26]. Sur-
viving null leaflets are truncated, containing ectopic cardio-
myocytes and smooth muscle, mis-expression of the carti-
lage proteoglycan aggrecan with disorganized matrix stratifi-
cation. This phenotype is consistent with the islands/pockets 
of cartilage reported in adult valves including mice and hu-
man [20, 27, 28], and with the phenotype of Smad6
-/- in 
which cartilage, bone, bone marrow, and even blood cells 
were formed within both AV and aortic valve leaflets [29]. 
Collectively, these findings suggest cushion cells are mul-
tipotential cells whose differentiation potential is normally 
restricted to primarily a fibroblastic lineage. Assessment of 
collagen production, 3D-lattice formation ability, and TGF-
responsiveness indicate that Postn-deficient fibroblasts are 
unable to support normal valvular remodeling [20]. Further-
more, null fibroblasts exhibit reduced ability to reorganize 
and contract 3D-collagen lattices, and a diminished response 
to increasing TGF concentrations. In fact, Postn can directly 
bind collagen type-I [10]. These observations collectively 
suggest that loss of Postn results in inappropriate differentia-
tion of mesenchymal cushions and valvular abnormalities via 
a TGF-dependent pathway during establishment of mature 
valve leaflets.  
 Alk3 (type IA receptor for bone morphogenic proteins 
(BMPs)) has been shown to be required for Postn expression 
in remodeling AV valves [30]. Postn was initially normally 
expressed in  cGata6-Cre/Alk3 mutant E11.5 cushions but 
was appreciably reduced in mutant E14.5 atrioventricular 
(AV) leaflets. Given that TGF2 expression is also de-
creased in Alk3
–/– mutants [31], the cardiac cushions of mu-
tant mice may therefore be
  hypoplastic secondary to de-
creased TGF2–mediated
 endocardial cushion EMT. In sup-
port of this, exogenous chick BMP2 or constitutively active 
Alk6 (type-IB BMP receptor) retrovirus significantly pro-
moted expression of Postn in AV cushion explant assays 
[32]. As BMP2 has also been shown to induce TGF2 in this 
culture system [33] and BMP2 is known to function syner-
gistically with TGF3 in the regulation of endocardial cush-
ion EMT [34],  BMPs  may  induce  Postn by activating
  an 
endocardial TGF autocrine loop. In explanted diseased pe-
diatric cardiac tissues from stenotic bicuspid aortic valves, 
Postn expression is largely absent from regions where ECM 
trilaminar stratification was lost, collagen fibrils disorgan-
ized and elastin fiber content reduced [20]. Combined with 
the mouse genetic disruption data, these results suggest that 
Postn  may be required in utero for events that manifest 
themselves in postnatal and adult life. Specifically, Postn 
plays multiple roles as a primary responder molecule and 
may be linked to ECM deposition/re-organization during 
maturation and homeostasis of fibrous valve leaflets and 
maintenance of PDL integrity in response to mechanical 
stresses.  
  Connective tissue disorders are among the most common 
congenital defects in humans and constitute numerous adult 
diseases. Cardiac valve thickening and aortic dilation are 
major cardiovascular phenotypes of Marfans, and Marfans-
like disorders, and are manifested through an alteration in 
collagen fibers and microfibril assembly [35]. Marfans pa-
tients have increased Postn protein as well as increased 
TGF and BMP signaling in their thickened heart valves, 
which suggests that Postn is positively regulated by TGF 
and BMP [36, 37]. Despite the complex and intriguing corre-
lation of deregulated Postn expression levels in both normal 
and pathological transformation conditions, very little is 
known about how Postn is transcriptionally controlled. Thus, 
unraveling the molecular mechanisms that regulate Postn 
expression could prove insightful. For example, during os-
teoblast differentiation, transcription of Postn may be regu-
lated by the bHLH transcription factor Twist, which itself is 
associated with EMT during tumor progression [38, 39]. A 
3.9kb  Postn proximal promoter region was isolated and 
shown to drive tissue-specific expression in the neural crest-
derived Schwann cell lineage and in a subpopulation of 
Postn-expressing cells in the cardiac outflow tract and endo-
cardial cushions [4]. Further analysis of the Postn promoter 
also implicated the ubiquitous transcription factor Ying 
Yang-1 (YY1) in regulating expression, which is interesting 
given YY1’s role as an initiator of tumorigenesis and inhibi-
tor of important cell-cycle progression genes [40-42]. Thus, 
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mechanisms might also suggest additional molecular path-
ways that underlie its developmental functions.  
ROLE OF Postn IN ADULT HEART DISEASE 
  It is likely that the developmental functions of Postn dis-
cussed above in facilitating proper organization of the ECM 
and in affecting cellular trafficking in remodeling hotspots is 
selectively re-employed in the adult organism. For example, 
Postn is expressed in collagen-rich connective tissues, re-
modeling centers, at sites of injury and inflammation, and is 
similarly induced by TGF- [9, 13, 19-21, 43-45]. Specifi-
cally, myocardial infarction (MI) or pressure overload stimu-
lation to the adult heart induces abundant re-expression of 
Postn from resident fibroblasts located between myocytes 
within the heart parachyma proper (Fig. 2A-C), where prior 
to such stimulation the major expression of Postn in the heart 
is within the collagen rich environment of the valves [20, 21, 
45-48]. Postn expression is also induced at sites of vascular 
injury and hyperplasia [18, 49, 50], in the lung after in-
jury/fibrosis [8, 51], in and around tumors [13], and at 
wound sites [52]. While not unequivocally proven, these 
various studies suggest a common biologic response 
whereby Postn becomes re-expressed at injury or inflamma-
tory sites within the adult organism, often associated with a 
need for ECM and cellular migration, not unlike many de-
velopmental processes associated with Postn expression. 
  The heart contains a fibrosis skeleton of collagen and 
other ECM components that maintains overall ventricular 
geometries and the proper organization of myocytes within 
aligned strips that wrap around the heart for optimal force 
generation [53]. Remodeling of the fibrous skeleton and the 
ECM surrounding individual myocytes is critically involved 
in hypertrophic and dilatory growth of the heart in response 
to either pathologic or physiologic stimulation [53]. Long-
standing pressure overload associated with hypertension, 
viral myocarditis, postpartum cardiomyopathy, and hyper-
trophic cardiomyopathy all induce significant alterations in 
the ECM and can lead to fibrotic heart disease and loss of 
ventricular compliance [54].
 MI associated with occlusion of 
a major coronary artery leads to rapid cell death of an entire 
region of the ventricular wall or septum, resulting in an in-
flammatory response and subsequent formation of a fibrous 
scar that is rich in collagen but lacking in contractile capacity 
[55]. As discussed above, Postn is minimally expressed in 
the adult ventricles unless a pathologic stress or injury oc-
curs. The function of Postn upon re-expression in the injured 
myocardium is currently an area of controversy given dispa-
rate accounts in the literature, although most reports suggest 
a function that is tied to the ECM, fibrotic remodeling, and 
the movement of cells through an injured or reorganizing 
area.  
  We reported that Postn
-/- mice had an altered fibrotic re-
sponse and were unable to form proper scars after MI injury, 
leading to greater rates of wall rupture and death [21], a re-
sult that was independently confirmed the following year in 
separately generated Postn null mice [45]. Conversely, we 
generated transgenic mice over expressing full-length Postn 
in the heart, which protected from wall rupture following MI 
injury [21]. Abundant Postn over expression in the heart did  
 
not induce fibrosis, although it did eventually promote a mild 
hypertrophy response that we interpret to be associated with 
integrin signaling (see below). Another interesting aspect of 
Postn
-/- mice is that they were less susceptible to fibrotic 
heart disease associated with long-term pressure overload or 
MI, resulting in better ventricular performance [21]. These 
results suggest that loss of Postn is actually protective to the 
heart long-term, provided the initial insult is survived during 
the scar formation period if the insult was an MI (1-7 days).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Distribution of endogenous Postn protein expression in 
adult mouse hearts at base line (A), subjected to pressure overload 
for 8 weeks (B), or 2 weeks after myocardial infarction (C). A 
Postn specific antibody was used (green fluorescence) and a myo-
cyte-specific contractile protein (red fluorescence). Panels B and C 
show abundant Postn protein accumulation in the extracellular 
space from the injury stimulus. 552    Current Genomics, 2008, Vol. 9, No. 8  Conway and Molkentin 
  Three other groups have also attempted to alter expres-
sion of Postn or an alternately spliced isoform of Postn in the 
adult heart to examine its role in cardiac adaptation or mal-
adaptation [23, 56, 57]. Katsuragi et al. attempted to aug-
ment or inhibit Postn expression in the adult rat heart using a 
plasmid DNA transfection protocol or a one-time infusion of 
antisense oligonucleotides, respectively [23]. Katsuragi et al. 
contended that using this method to over express Postn 
caused ventricular dilation and reduced cardiac function, 
although Postn protein expression was not examined, render-
ing these results difficult to interpret. This pathologic pheno-
type associated with Postn plasmid DNA transfection is also 
in stark contrast to data obtained in Postn over expressing 
transgenic mice, which showed no such effect, even at high 
levels of sustained expression for up to 12 months [21]. In 
another study, Litvin et al. injected an adenovirus encoding 
an alternatively spliced isoform of Postn (called PLF) into 
the heart, which after 7 days caused a minor increase in car-
diac hypertrophy [56]. These results are consistent with 
Postn transgenic mice [21], although the adenoviral approach 
employed by Litvin et al. may have hastened the hypertro-
phic response due to the adenoviral infection itself. Thus, 
over expression of Postn is relatively innocuous to the adult 
heart, although it does eliminate rupture susceptibility fol-
lowing MI and it can produce a mild hypertrophy response 
with aging. 
  Results reported from a third group are perhaps the most 
controversial, as they suggest an entirely novel function for 
Postn in mediating cardiomyocyte proliferation and the sub-
sequent repair of injured myocardium [57]. In addition to 
reporting increased proliferation, Kühn et al. claimed that 
Postn prevented fibrosis and reduced cardiac hypertrophy 
after an injury event, results that are not consistent with Oka 
et al. [21]. A potential reason for these differences may be 
that Kühn et al. utilized a recombinant truncated form of 
Postn (amino acids 22-669 of 811) in ascribing biological 
effects [57]. Using this partial protein, as well as a full-
length protein, the authors reported increased proliferation 
rates in adult rat cardiac myocytes cultured for 9 days [57]. 
These later results may also be compromised given the 
known process of de-differentiation that occurs in adult 
myocytes cultured for this length of time, possibly rendering 
the cells artificially permissive to proliferation. More re-
markably, Kühn et al. reported that application of the trun-
cated form of Postn with a gelfoam patch onto infarcted 
hearts reduced fibrosis, reduced cardiac hypertrophy, in-
creased myocyte proliferation, and improved cardiac func-
tion [57].
 However, over expression of full-length Postn in 
the mouse heart by transgenesis (from the cardiomyocytes-
restricted -myosin heavy chain promoter), which results in 
the proper accumulation of Postn protein in the ECM with-
out detectable intracellular retention, did not increase myo-
cyte number at baseline, nor did it augment indices associ-
ated with cardiac repair after MI injury [21]. Moreover, Oka 
et al. reported that Postn
-/- mice had reduced fibrosis and 
improved function after MI, provided they did not succumb 
to wall rupture, and Postn over expressing transgenic mice 
actually developed cardiac hypertrophy and were not pro-
tected from negative remodeling and fibrosis after MI [21]. 
Thus, the in vivo results of Kühn et al. are essentially oppo-
site of Oka et al. While multiple reasons may underlie these 
differences, Oka et al. relied on genetically modified mice to 
alter Postn expression compared with non-genetic ap-
proaches by Kühn et al. in which recombinant and truncated 
Postn was employed in conjunction with a questionable con-
trol group. For example, the control group for the MI results 
of Kühn et al. simply relied on buffer treatment [57]. A more 
reliable control would have been the use of gelfoam patches 
loaded with a non-specific recombinant protein generated in 
E. coli with the same potential for LPS contamination or the 
effects of the gelfoam patch itself. Thus, the contention that 
Postn promotes physiologically meaningful cardiac myocyte 
proliferation in the heart following MI injury is far from es-
tablished. We favor the alternate hypothesis that Postn 
mostly functions in collagen fibrillogenesis and cellular re-
modeling. 
Postn SIGNALING MECHANISMS IN THE ADULT 
HEART 
  Alterations in cardiac remodeling and hypertrophy at the 
hands of Postn might occur by two different, but potentially 
overlapping mechanisms. Postn might simply regulate the 
integrity of the ECM through its ability to bind multiple 
ECM proteins, such as tenascin-C, fibronectin, collagen V, 
collagen I, aggrecan and heparin, thus affecting the structural 
integrity of the adult heart matrix or stretch-sensitive signal-
ing [8, 10, 58]. Indeed, collagen fibrils from Postn
-/- mice 
were reduced in size, somewhat disorganized, and less effi-
ciently cross-linked [10, 45]. The Postn
lacZ/lacZ PDL ECM is 
disorganized and exhibits a reduced ability to absorb masti-
catory mechanical stresses [24].
 Similarly, skin from Postn
-/- 
mice has lower tensile strength and a difference in elasticity 
[10]. Hence, Postn may secondarily impact the structural 
properties of the heart by altering the composition and per-
formance of the ECM. Such alterations in the ECM could 
easily affect cardiac remodeling by simply modifying the 
strength and stretch characteristics of the tissue with a com-
mensurate impact on valvular closing and myocyte signal 
transduction. Another related issue is that Postn appears to 
be a more pliable substrate compared with fibronectin and 
vitronectin, likely affecting how mesenchymal cells (fibro-
blasts, inflammatory cells, stem cells) migrate within the 
heart following injury [11]. Indeed, work in the cancer field 
has shown that transformed cells preferentially secrete Postn 
to facilitate invasiveness and metastatic activity [11, 12, 59]. 
This same static feature of ECM pliability may also underlie 
invasiveness of mesenchymal cells into endocardial cushions 
in the presence of Postn in the developing heart valves [19].  
  A second potential mechanism whereby Postn affects the 
phenotype of the adult heart is by attachment-dependent sig-
naling through cell adhesion molecules. Postn is an integrin 
binding protein and its attachment with fibroblasts or myo-
cytes may impart a signal that affects how these cells per-
ceive their environment and respond to stress or other re-
modeling signals. As mentioned earlier, Postn supports v3, 
v5, and 46, integrin attachment/signaling to facilitate 
EMT and metastatic activity [11, 59], as well as movement 
of cells within the developing bone centers and PDLs [11, 
22, 9, 12, 24]. This integrin dependent interaction could im-
part a direct signal to cardiac myocytes that affects their hy-
pertrophic growth or the milieu of other cells that surround 
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might serve as a unique substrate for various inflammatory, 
mesenchymal, and stem cells to signal the need for repair in 
a given region of the myocardium based on unique integrin 
attachment properties. Finally, Postn might also signal 
through a homotypic interaction with the membrane bound 
fasciclin domain containing receptors Stab-1 or Stab-2 found 
on inflammatory or mesenchymal cells. Indeed, Stab-1 is 
highly expressed on macrophages and adjacent endothelial 
cells where it might be attracted to or modified within the 
injury area through a homotypic interaction with Postn 
and/or Tgfbi [4, 60, 61].  
  It has also been reported that a “periostin-like factor” 
(PLF) may be over expressed in failing human and rat car-
diomyocytes and is localized to the cardiac myocyte itself 
[56]. However, PLF is actually one of four Postn isoforms 
expressed in the heart, and all four isoforms are missing in 
Postn
lacZ/lacZ mice using a highly characterized antibody (Fig. 
3A-D) [62]. This differentially spliced non-secreted isoform 
was originally identified by Kudo et al. [63]. Thus it is un-
clear why this particular Postn isoform was renamed PLF. 
Despite these issues, none of the alternately spliced isoforms 
off Postn are expressed in myocytes, and all appear to be 
exclusively made in fibroblasts from within the heart [10, 20, 
21].  
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